Serena Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2001.
2001 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Serena Pharma Private Limited

Serena Pharma Private Limited, a active private limited company, was established on 03 April 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239MH2001PTC131489. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Sujit Kumar Singh (Director), Himanshu Baldev Singh (Director). Past directors included Sheel Kumar Dhananjay Singh, Radhe Krishan Nagpal, Shirish Rajaram Gholkar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shreya House 4Th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, 400099.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2001PTC131489

  • Registration Number

    131489

  • Incorporation Date

    03 April 2001

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 24 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 10612.80%
  • Ebitda **** 15622.16%
  • Net Worth 4158.18%
  • Total Assets **** 3774.64%
Company report

Serena Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Serena Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Serena Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sujit Kumar Singh Director 03 Apr 2001 Current
Himanshu Baldev Singh Director 06 Nov 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Mar 2019 Past
Pramod Abcsdd Director 06 Nov 2009 Past
Pramod Abcsdd Director 01 Dec 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Serena Pharma.

Serena Pharma Private Limited, for the financial year ended 2025, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 10612.8% increase in profit. The company's net worth Soared by an impressive increase of 4158.18%.

Serena Pharma revenue growth over time
Serena Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 3774.64%
*******
*******
*******
*******
Profit or Loss
*******
 10612.80%
*******
*******
*******
*******
Net Worth
*******
 4158.18%
*******
*******
*******
*******
EBITDA
*******
 15622.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Serena Pharma?

Unlock access to Serena Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Serena Pharma?

Unlock and access historical data on people associated with Serena Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Serena Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serena Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Serena Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Serena Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Serena Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Himanshu Baldev Singh was appointed as a Director was appointed as a Director on 06 Nov 2009 & has been associated with this company since 16 years 4 months . was recorded as a recent event.

  • Director Appointment

    Sujit Kumar Singh was appointed as a Director was appointed as a Director on 03 Apr 2001 & has been associated with this company since 24 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Serena Pharma Private Limited was registered on 03 Apr 2001 with Roc Mumbai & aged 24 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Serena Pharma Private Limited?

The CIN of Serena Pharma Private Limited is U24239MH2001PTC131489.

Where is Serena Pharma Private Limited headquartered?

Serena Pharma Private Limited is headquartered at Shreya House 4Th Floor301/A Pereira Hill Road Andheri (West), Mumbai, Maharashtra, 400099.

When was Serena Pharma Private Limited incorporated?

Serena Pharma Private Limited was incorporated on 03 April 2001.

Who are the current directors of Serena Pharma Private Limited?

The current directors of Serena Pharma Private Limited are

What is the primary industry of Serena Pharma Private Limited?

The primary industry of Serena Pharma Private Limited is Trade.

Is Serena Pharma Private Limited a listed company?

Serena Pharma Private Limited is unlisted.

What is the capital structure of Serena Pharma Private Limited?

The authorized capital of Serena Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Serena Pharma Private Limited?

The compliance status of Serena Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available